The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Compugen Ltd. / See Company Profile

Alliance / Compugen and MedImmune enter exclusive license agreement / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 3, 2018

Alliance / Bayer receives global license to Compugen’s cancer immunotherapeutics / Strategic Transactions / Deal Date: Aug. 1, 2013 / Update Date: Jul. 1, 2017

Financing / Public stock sale nets $68mm for Compugen / Strategic Transactions / Deal Date: Feb. 1, 2014 / Publish Date: Mar. 4, 2014

OSE Immunotherapeutics SA / See Company Profile

Alliance / BI acquires exclusive worldwide license to OSE Immunotherapeutics' mAb OSE172 / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 6, 2018

Acquisition / OSE Pharma and Effimune to merge / Strategic Transactions / Deal Date: Feb. 1, 2016 / Publish Date: Jan. 6, 2017

Alliance / Servier gets option to OSE Immunotherapeutics' Effi7 / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Jan. 5, 2017

Homology Medicines Inc. / See Company Profile

Financing / Genetic medicines start-up Homology nets $154mm in IPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 3, 2018

Alliance / Novartis uses Homology's AMEnDR gene editing platform to develop ophthalmic, blood disorder therapeutics / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 15, 2017

Financing / Homology Medicines raises $83.5mm in Series B round / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 3, 2017


Medical Devices

Email Alert | RSS Feed

Securus Medical Group Inc. / See Company Profile

Acquisition / Boston Scientific buys Securus Medical for $40mm / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 3, 2018

Financing / Thermal measuring device company Securus Medical Group raises $10mm in Series C round / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Sep. 27, 2016

Financing / Series B brings in $6.5mm for Securus Medical / Strategic Transactions / Deal Date: Oct. 1, 2013 / Publish Date: Nov. 8, 2013

NxThera Inc. / See Company Profile

Acquisition / Boston Scientific acquires urology device company NxThera for $306mm, plus earn-outs / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 27, 2018

Financing / NxThera closes $40mm Series D round / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 3, 2015

Financing / Series C venture round brings in over $20mm for NxThera / Strategic Transactions / Deal Date: Aug. 1, 2013 / Update Date: Feb. 1, 2014

Strata Skin Sciences Inc. / See Company Profile

Financing / Strata Skin Sciences raises $17mm in PIPE; Accelmed gains majority stake / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 6, 2018

Acquisition / Mela acquires PhotoMedex's XTRAC, VTRAC businesses for $42.5mm / Strategic Transactions / Deal Date: Jun. 1, 2015 / Publish Date: Jun. 29, 2015

Financing / Mela raises $42.5mm in debt financing to fund PhotoMedex deal / Strategic Transactions / Deal Date: Jun. 1, 2015 / Publish Date: Jun. 29, 2015


In Vitro Diagnostics

Email Alert | RSS Feed

Agilent Technologies Inc. / See Company Profile

Acquisition / Agilent exercises option to acquire remaining 52% in Lasergen for $105mm / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 4, 2018

Alliance / Agilent invests $80mm in NGS company Lasergen; has option to acquire remainder; option exercised / Strategic Transactions / Deal Date: Mar. 1, 2016 / Update Date: Apr. 1, 2018

Acquisition / Agilent Technologies agrees to acquire Advanced Analytical Technologies / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 9, 2018

MDxHealth SA / See Company Profile

Financing / MDxHealth raises €36mm through capital increase / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Alliance / QUT bluebox and MDxHealth ally for oral cancer liquid biopsy test / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jul. 6, 2017

Alliance / Exact Sciences licenses biomarkers from OncoMethylome / Strategic Transactions / Deal Date: Jul. 1, 2010 / Update Date: Apr. 1, 2017

Invitae Corp. / See Company Profile

Financing / Invitae nets $47mm via FOPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Acquisition / Invitae acquires perinatal testing firm Good Start for $40mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Financing / Invitae sells $73.5mm of its common and preferred shares through private placement / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017


Pharmaceuticals

Email Alert | RSS Feed

Inception 5 Inc. / See Company Profile

Acquisition / Roche exercises option for multiple sclerosis company Inception 5 / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 6, 2018

Alliance / Latest Inception Sciences experiment to tackle MS; Roche has option to buy Inception 5; exercised / Strategic Transactions / Deal Date: Jun. 1, 2014 / Update Date: Mar. 1, 2018

Financing / Inception 5, focused on multiple sclerosis, gets funding from Versant / Strategic Transactions / Deal Date: Jun. 1, 2014 / Publish Date: Jun. 24, 2014

Indivior PLC / See Company Profile

Alliance / Indivior licenses global rights to C4X's C4X3256 for addiction / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 3, 2018

Alliance / Indivior boosts addiction pipeline with exclusive global rights to Addex's ADX71441 / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 5, 2018

Alliance / Indivior buys Durect's drug delivery IP / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 4, 2017

Rhythm Pharmaceuticals Inc. / See Company Profile

Alliance / Rhythm takes rights to Takeda's Prader-Willi candidate / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 4, 2018

Financing / Rhythm Pharmaceuticals nets $128.1mm via IPO / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 9, 2017

Alliance / Rhythm to develop new formulation of setmelanotide using Camurus' FluidCrystal technology / Strategic Transactions / Deal Date: Jan. 1, 2016 / Update Date: Jun. 1, 2017

Biotechnology

Biotechnology

Email Alert | RSS Feed

Compugen Ltd. / See Company Profile

Alliance / Compugen and MedImmune enter exclusive license agreement / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 3, 2018

Alliance / Bayer receives global license to Compugen’s cancer immunotherapeutics / Strategic Transactions / Deal Date: Aug. 1, 2013 / Update Date: Jul. 1, 2017

Financing / Public stock sale nets $68mm for Compugen / Strategic Transactions / Deal Date: Feb. 1, 2014 / Publish Date: Mar. 4, 2014

OSE Immunotherapeutics SA / See Company Profile

Alliance / BI acquires exclusive worldwide license to OSE Immunotherapeutics' mAb OSE172 / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 6, 2018

Acquisition / OSE Pharma and Effimune to merge / Strategic Transactions / Deal Date: Feb. 1, 2016 / Publish Date: Jan. 6, 2017

Alliance / Servier gets option to OSE Immunotherapeutics' Effi7 / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Jan. 5, 2017

Homology Medicines Inc. / See Company Profile

Financing / Genetic medicines start-up Homology nets $154mm in IPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 3, 2018

Alliance / Novartis uses Homology's AMEnDR gene editing platform to develop ophthalmic, blood disorder therapeutics / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 15, 2017

Financing / Homology Medicines raises $83.5mm in Series B round / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 3, 2017

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Securus Medical Group Inc. / See Company Profile

Acquisition / Boston Scientific buys Securus Medical for $40mm / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 3, 2018

Financing / Thermal measuring device company Securus Medical Group raises $10mm in Series C round / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Sep. 27, 2016

Financing / Series B brings in $6.5mm for Securus Medical / Strategic Transactions / Deal Date: Oct. 1, 2013 / Publish Date: Nov. 8, 2013

NxThera Inc. / See Company Profile

Acquisition / Boston Scientific acquires urology device company NxThera for $306mm, plus earn-outs / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 27, 2018

Financing / NxThera closes $40mm Series D round / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 3, 2015

Financing / Series C venture round brings in over $20mm for NxThera / Strategic Transactions / Deal Date: Aug. 1, 2013 / Update Date: Feb. 1, 2014

Strata Skin Sciences Inc. / See Company Profile

Financing / Strata Skin Sciences raises $17mm in PIPE; Accelmed gains majority stake / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 6, 2018

Acquisition / Mela acquires PhotoMedex's XTRAC, VTRAC businesses for $42.5mm / Strategic Transactions / Deal Date: Jun. 1, 2015 / Publish Date: Jun. 29, 2015

Financing / Mela raises $42.5mm in debt financing to fund PhotoMedex deal / Strategic Transactions / Deal Date: Jun. 1, 2015 / Publish Date: Jun. 29, 2015

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Agilent Technologies Inc. / See Company Profile

Acquisition / Agilent exercises option to acquire remaining 52% in Lasergen for $105mm / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 4, 2018

Alliance / Agilent invests $80mm in NGS company Lasergen; has option to acquire remainder; option exercised / Strategic Transactions / Deal Date: Mar. 1, 2016 / Update Date: Apr. 1, 2018

Acquisition / Agilent Technologies agrees to acquire Advanced Analytical Technologies / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 9, 2018

MDxHealth SA / See Company Profile

Financing / MDxHealth raises €36mm through capital increase / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Alliance / QUT bluebox and MDxHealth ally for oral cancer liquid biopsy test / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jul. 6, 2017

Alliance / Exact Sciences licenses biomarkers from OncoMethylome / Strategic Transactions / Deal Date: Jul. 1, 2010 / Update Date: Apr. 1, 2017

Invitae Corp. / See Company Profile

Financing / Invitae nets $47mm via FOPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Acquisition / Invitae acquires perinatal testing firm Good Start for $40mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Financing / Invitae sells $73.5mm of its common and preferred shares through private placement / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Inception 5 Inc. / See Company Profile

Acquisition / Roche exercises option for multiple sclerosis company Inception 5 / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 6, 2018

Alliance / Latest Inception Sciences experiment to tackle MS; Roche has option to buy Inception 5; exercised / Strategic Transactions / Deal Date: Jun. 1, 2014 / Update Date: Mar. 1, 2018

Financing / Inception 5, focused on multiple sclerosis, gets funding from Versant / Strategic Transactions / Deal Date: Jun. 1, 2014 / Publish Date: Jun. 24, 2014

Indivior PLC / See Company Profile

Alliance / Indivior licenses global rights to C4X's C4X3256 for addiction / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 3, 2018

Alliance / Indivior boosts addiction pipeline with exclusive global rights to Addex's ADX71441 / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 5, 2018

Alliance / Indivior buys Durect's drug delivery IP / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 4, 2017

Rhythm Pharmaceuticals Inc. / See Company Profile

Alliance / Rhythm takes rights to Takeda's Prader-Willi candidate / Strategic Transactions / Deal Date: Apr. 1, 2018 / Publish Date: Apr. 4, 2018

Financing / Rhythm Pharmaceuticals nets $128.1mm via IPO / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 9, 2017

Alliance / Rhythm to develop new formulation of setmelanotide using Camurus' FluidCrystal technology / Strategic Transactions / Deal Date: Jan. 1, 2016 / Update Date: Jun. 1, 2017

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel